hesperetin has been researched along with Carcinoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, W; Song, J; Wang, J; Wu, D; Zhang, J | 1 |
Borradaile, NM; de Dreu, LE; Huff, MW; Wilcox, LJ | 1 |
2 other study(ies) available for hesperetin and Carcinoma, Hepatocellular
Article | Year |
---|---|
Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Calcium; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; Cytoplasm; Hesperidin; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Reactive Oxygen Species; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
Topics: Anticholesteremic Agents; Apolipoproteins B; Carcinoma, Hepatocellular; Carrier Proteins; Cholesterol; Cholesterol Esters; Citrus; Enzyme-Linked Immunosorbent Assay; Flavanones; Flavonoids; Hepatocytes; Hesperidin; Humans; Receptors, LDL; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides; Tumor Cells, Cultured | 2001 |